The KTN1 Knockout HAP1 Polyclonal Cells constitute a CRISPR/Cas9-edited polyclonal knockout cell population designed to disrupt the KTN1 gene in the near-haploid human HAP1 cell line. This product provides a pooled population of cells carrying heterogeneous KTN1 gene disruptions, enabling functional studies of kinectin 1 in a genetically simplified background. As a polyclonal knockout model, it circumvents the selection of a single clone and preserves population-level diversity, making it suitable for pooled screening and bulk assays where clonal artifacts are undesirable. The knockout model serves as a loss-of-function tool to investigate the cellular consequences of KTN1 deficiency, including organelle dynamics, intracellular transport, and signaling pathway modulation.
The host cell line, HAP1, is an adherent, near-haploid human chronic myeloid leukemia (CML) cell line derived from KBM-7. It retains a BCR-ABL oncogene and a single copy of most chromosomes, which facilitates unambiguous gene disruption and straightforward genotype?Cphenotype correlation. This near-haploid karyotype reduces the complexity associated with secondary mutations and compensatory mechanisms often observed in diploid cell lines, making HAP1 a preferred system for functional genomics, drug target validation, and CRISPR-based screening. Its adherent growth enables imaging-based assays and migration studies, complementing its genetic tractability.
Kinectin 1, encoded by KTN1, is an integral endoplasmic reticulum (ER) membrane protein that anchors kinesin-1 motor complexes to organelles, thereby mediating microtubule-dependent transport. KTN1 directly interacts with the kinesin heavy chain KIF5B and the light chain KLC1 to form the KTN1/KIF5B/KLC motor complex, which drives the movement of ER tubules, lysosomes, and mitochondria. This transport function is critical for ER network organization and organelle distribution. In signaling contexts, KTN1 participates in integrin ??1 (ITGB1)-dependent activation of focal adhesion kinase (FAK) and the NF-??B pathway, influencing transcriptional programs that govern cell migration, survival, and proliferation. Additionally, KTN1 facilitates RAB7-positive late endosome/lysosome positioning and DRP1-dependent mitochondrial fission, linking its roles in vesicular trafficking and organelle dynamics.
In the HAP1 cellular context, KTN1 knockout disrupts these critical transport and signaling functions, leading to impaired ER tubulation, aberrant lysosomal clustering, altered mitochondrial morphology, and reduced integrin-dependent NF-??B activation. These defects collectively manifest as diminished cell migration and increased susceptibility to apoptotic stimuli, providing a robust phenotypic readout for functional studies. The near-haploid background of HAP1 ensures that the observed effects are directly attributable to KTN1 loss without confounding allelic heterogeneity. This knockout model is therefore ideal for dissecting the molecular requirements for KTN1 in organelle positioning and integrin signaling cascades, and for screening chemical or genetic modifiers of these processes.
The KTN1 Knockout HAP1 Polyclonal Cells are well-suited for a range of applications, including high-content immunofluorescence microscopy to visualize ER, lysosomal, and mitochondrial morphology abnormalities; wound healing and transwell migration/invasion assays to assess cell motility alterations; NF-??B luciferase reporter assays to quantify signaling changes; and flow cytometry-based analysis of integrin expression and apoptosis. Moreover, this polyclonal population can be employed in pooled functional genomics screens and drug target validation studies for hepatocellular carcinoma, breast cancer metastasis, and neurodegenerative diseases. For further information or support with integrating this model into your research, please contact Ascent Research.
